Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes
In conclusion DOACs appear to be a safe alternative to warfarin in patients with mild to moderate cirrhosis. Further studies are warranted to confirm these findings.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Bleeding | Cirrhosis | Coumadin | Hematology | Stroke | Study | Thrombosis | Vitamin K | Vitamins | Warfarin